Recent

% | $
Quotes you view appear here for quick access.

Ironwood Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • aany23 aany23 Dec 11, 2012 4:09 PM Flag

    IRWD owns a key patent on plecanatide

    this was settled. do your homework

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The LOI they announced means nothing. The terms will have to be negotiated out to IRWD's satisfaction, otherwise no deal. IRWD will play these guys, and as I said has them over a barrel.

      • 2 Replies to jrus2010
      • Your an idiot. Terms have already been negotiated.SGYP is going to pay IRWD a "MODEST" royalty.News has been out for awhile, where have you been?

      • The LOI is binding and the broad terms have been outlined and already agreed upon (i.e. royalty limits, global license, etc). Overstating things you don't know about is pathetic. You have no direct line of sight regarding the remaining negotiating points, and logic dictates that both sides had proper legal council and appropriately covered their liabilities.

        Additionally, Ironwood only holds a flimsy method of use patent, not a product patent. And since they have failed to mobilize development activities towards commercialization of a product as defined under the Hatch-Waxman act, Synergy could have easily challenged and won (with high probability) a legal ruling without entering any agreement with Ironwood.

        Bottom line: This agreement clears the way for SGYP to either partner or sell once they've cleared the clinical hurdle in early January.

 
IRWD
14.86-0.24(-1.62%)12:39 PMEDT